Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00932295 · ClinicalTrials.gov registry record · Phase 1
Evaluating the Acute Effects of Electronic Nicotine Delivery Devices Marketed to Smokers.
A Phase 1 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT00932295 is a Phase 1 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 32 participants.
The verdict
NCT00932295, a Phase 1 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
The study's aim is to develop a clinical model that can be used to measure the nicotine delivery and tobacco/nicotine abstinence-suppressing capability of electronic devices that are marketed as a means to deliver nicotine to cigarette smokers. The study will compare the nicotine delivery, cardiovascular effects, and tobacco withdrawal suppressing effects of two devices currently marketed in the U.S.: Crown Seven and NJOY. Specifically, the effects of these devices will be compared with the effects of own brand cigarettes (positive control), and an abstinence condition (sham smoking; puffing from an unlit cigarette). The primary hypothesis is that the nicotine delivery, withdrawal suppression, and other effects of electronic devices marketed as a means to deliver nicotine to smokers can be measured during a period of acute exposure.
Interventions
- OTHER OB
- OTHER Sham smoking
- OTHER CROWN SEVEN
- OTHER NJOY
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00932295
The ClinicalTrials.gov registry entry for NCT00932295 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which OB is the first listed.
NCT00932295 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00932295 about?
NCT00932295 is a clinical study titled "Evaluating the Acute Effects of Electronic Nicotine Delivery Devices Marketed to Smokers.". The study's aim is to develop a clinical model that can be used to measure the nicotine delivery and tobacco/nicotine abstinence-suppressing capability of electronic devices that are marketed as a means to deliver nicotine to cigarette smokers. The study will compare the nicotine delivery, cardiovas...
What is the current status of trial NCT00932295?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2009-02. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00932295?
The interventions under investigation include: OB (OTHER), Sham smoking (OTHER), CROWN SEVEN (OTHER), NJOY (OTHER).
Who is sponsoring clinical trial NCT00932295?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.